SCHEMBL7779618

SCHEMBL7779618

Cc1[nH]nc(-c2ccc(S(C)(=O)=O)cc2)c1-c1ccc(Cl)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.57
PTGS1 P23219 4/20 0.57
IKBKB O14920 1/20 0.53
MAP3K14 Q99558 1/20 0.53
ALOX12 P18054 3/20 0.52
MEN1 O00255 2/20 0.52
CYP1A2 P05177 2/20 0.52
CYP3A4 P08684 2/20 0.52
CYP2D6 P10635 2/20 0.52
MAPT P10636 2/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
KMT2A Q03164 2/20 0.52
NPSR1 Q6W5P4 2/20 0.52
GPR55 Q9Y2T6 2/20 0.52
GAA P10253 2/20 0.52
ALOX15 P16050 2/20 0.52
MAPK1 P28482 2/20 0.52
GYS1 P13807 1/20 0.52
HTT P42858 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780738 0.89 LRRK2 (0.60) PTGS2PTGS1IKBKBMAP3K14ALOX12
SCHEMBL7777645 0.83 PTGS2 (0.54) PTGS2PTGS1
SCHEMBL7780834 0.82 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL7778056 0.82 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL7772868 0.82 PTGS2 (0.54) PTGS2PTGS1
SCHEMBL7779303 0.82 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL8628027 0.82 GYS1 (0.53) PTGS2PTGS1GYS1LRRK2
SCHEMBL24964988 0.81 IKBKB (0.58) IKBKBMAP3K14ALOX12MEN1CYP1A2
SCHEMBL7778131 0.81 PTGS2 (0.50) PTGS2PTGS1GYS1LRRK2
SCHEMBL7779606 0.81 PTGS2 (0.50) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed